Country Overviews

Critical information and statistics on national and regional health infrastructure and provision. An essential source of detailed key business data on this fast growing economy.  |  more...

... on the healthcare, regulatory and reimbursement landscape of Singapore. The report identifies the key trends in the healthcare market of Singapore. The report also provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure ...  |  more...

... a result of the increased prevalence of chronic disease with age, thereforeconsuming a disproportionately large share of healthcare services. Such robust demand for services overthe coming years means the government will need to adapt strategies ...  |  more...

... maintain it is highly unlikely the Canadian governmentwill introduce punitive price controls like those witnessed across Europe. Instead, the country’shealthcare market will continue to place downward pressures on pharmaceutical prices as policiesmandating generic substitution compress ...  |  more...

... of individual funding for medicines, given the high out-of-pocketcontribution to healthcare. Nevertheless, volume demand will continue to grow on the back of demographic andepidemiological changes, supported by the expansion of modernisation of healthcare provision in ...  |  more...

... significantly affectdrugmaker revenues, threatening Spain’s attractiveness as a location in which to sell drugs, especially aspublic health spending accounts for 71% of total health expenditure. Headline Expenditure Projections .. Pharmaceuticals: EUR14.65bn (US$20.51bn) in 2011 to ...  |  more...

... With the most recent Sudanese civil war ended in 2005 after more than 20 years offighting, tension remains high and violent clashes between forces in South Sudan and its northernneighbour continue. It is clear that ...  |  more...

... the pharmaceutical market will achieve elevated growth over thenext five years and this view has been reinforced by the latest available trade data. However, the countryeconomic growth path is dependent on the stability of the ...  |  more...

... expected to push skilled staff to emigrate, leaving fewer candidatesto fill existing jobs. Indeed, despite signs that some multinational pharmaceutical companies areexpanding manufacturing facilities in Puerto Rico, we believe the outlook for the island's crucialpharmaceutical ...  |  more...

... biomedical manufacturing, whichwill remain of interest to multinationals. However, in line with the need to reduce public sectorexpenditure, generic drugs are expected to remain a focus in government hospitals. Headline Expenditure Projections .. Pharmaceuticals: SGD901mn ...  |  more...

... and drugmakers consistently recorded double-digit growth. Thegovernment is currently looking to reduce expenditure and excessive healthcare spending and the sectoris being targeted for cuts. We do not, however, expect any fundamental changes to the public-fundedindustry ...  |  more...

... reform. The acquisition of market leader Chimpharm and the reported imminent sale of a large stake in top-three player Global Pharm to a Turkish buyer reflect the strength of the market. Clearly, the provision of ...  |  more...